Role of poly(ADP-ribose) synthetase in inflammation

Research output: Contribution to journalArticle

87 Citations (Scopus)

Abstract

Peroxynitrite and hydroxyl radicals are potent initiators of DNA single strand breakage, which is an obligatory stimulus for the activation of the nuclear enzyme poly(ADP-ribose)synthetase (PARS). Rapid activation of PARS depletes the intracellular concentration of its substrate, NAD+, slowing the rate of glycolysis, electron transport and ATP formation. This process can result in acute cell dysfunction and cell necrosis. Accordingly, inhibitors of PARS protect against cell death under these conditions. In addition to the direct cytotoxic pathway regulated by DNA injury and PARS activation, PARS also appears to modulate the course of inflammation by regulating the expression of a number of genes, including the gene for intercellular adhesion molecule 1, collagenase and the inducible nitric oxide synthase. The research into the role of PARS in inflammatory conditions is now supported by novel tools, such as novel, potent inhibitors of PARS, and genetically engineered animals lacking the gene for PARS. In vivo data demonstrate that inhibition of PARS protects against various forms of inflammation, including zymosan or endotoxin induced multiple organ failure, arthritis, allergic encephalomyelitis, and diabetic islet cell destruction. Pharmacological inhibition of PARS may be a promising novel approach for the experimental therapy of various forms of inflammation.

Original languageEnglish (US)
Pages (from-to)1-19
Number of pages19
JournalEuropean Journal of Pharmacology
Volume350
Issue number1
DOIs
StatePublished - May 29 1998
Externally publishedYes

Fingerprint

Poly Adenosine Diphosphate Ribose
Ligases
Inflammation
Genes
Investigational Therapies
Genetically Modified Animals
Peroxynitrous Acid
Enzyme Activation
Zymosan
Multiple Organ Failure
Autoimmune Experimental Encephalomyelitis
Nitric Oxide Synthase Type II
Collagenases
Glycolysis
Intercellular Adhesion Molecule-1
Electron Transport
Islets of Langerhans
Endotoxins
Hydroxyl Radical
NAD

Keywords

  • 3-Aminobenzamide
  • Diabetes
  • Endotoxin
  • Free radical
  • Inflammation
  • Mitochondrial respiration
  • Nicotinamide
  • Nitric oxide, (NO)
  • Peroxynitrite
  • Poly(ADP-ribose)synthetase
  • Septic shock
  • Stroke
  • Superoxide

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Pharmacology

Cite this

Role of poly(ADP-ribose) synthetase in inflammation. / Szabo, Csaba.

In: European Journal of Pharmacology, Vol. 350, No. 1, 29.05.1998, p. 1-19.

Research output: Contribution to journalArticle

@article{7ec39ab51b29437195295ee8004e6c2e,
title = "Role of poly(ADP-ribose) synthetase in inflammation",
abstract = "Peroxynitrite and hydroxyl radicals are potent initiators of DNA single strand breakage, which is an obligatory stimulus for the activation of the nuclear enzyme poly(ADP-ribose)synthetase (PARS). Rapid activation of PARS depletes the intracellular concentration of its substrate, NAD+, slowing the rate of glycolysis, electron transport and ATP formation. This process can result in acute cell dysfunction and cell necrosis. Accordingly, inhibitors of PARS protect against cell death under these conditions. In addition to the direct cytotoxic pathway regulated by DNA injury and PARS activation, PARS also appears to modulate the course of inflammation by regulating the expression of a number of genes, including the gene for intercellular adhesion molecule 1, collagenase and the inducible nitric oxide synthase. The research into the role of PARS in inflammatory conditions is now supported by novel tools, such as novel, potent inhibitors of PARS, and genetically engineered animals lacking the gene for PARS. In vivo data demonstrate that inhibition of PARS protects against various forms of inflammation, including zymosan or endotoxin induced multiple organ failure, arthritis, allergic encephalomyelitis, and diabetic islet cell destruction. Pharmacological inhibition of PARS may be a promising novel approach for the experimental therapy of various forms of inflammation.",
keywords = "3-Aminobenzamide, Diabetes, Endotoxin, Free radical, Inflammation, Mitochondrial respiration, Nicotinamide, Nitric oxide, (NO), Peroxynitrite, Poly(ADP-ribose)synthetase, Septic shock, Stroke, Superoxide",
author = "Csaba Szabo",
year = "1998",
month = "5",
day = "29",
doi = "10.1016/S0014-2999(98)00249-0",
language = "English (US)",
volume = "350",
pages = "1--19",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Role of poly(ADP-ribose) synthetase in inflammation

AU - Szabo, Csaba

PY - 1998/5/29

Y1 - 1998/5/29

N2 - Peroxynitrite and hydroxyl radicals are potent initiators of DNA single strand breakage, which is an obligatory stimulus for the activation of the nuclear enzyme poly(ADP-ribose)synthetase (PARS). Rapid activation of PARS depletes the intracellular concentration of its substrate, NAD+, slowing the rate of glycolysis, electron transport and ATP formation. This process can result in acute cell dysfunction and cell necrosis. Accordingly, inhibitors of PARS protect against cell death under these conditions. In addition to the direct cytotoxic pathway regulated by DNA injury and PARS activation, PARS also appears to modulate the course of inflammation by regulating the expression of a number of genes, including the gene for intercellular adhesion molecule 1, collagenase and the inducible nitric oxide synthase. The research into the role of PARS in inflammatory conditions is now supported by novel tools, such as novel, potent inhibitors of PARS, and genetically engineered animals lacking the gene for PARS. In vivo data demonstrate that inhibition of PARS protects against various forms of inflammation, including zymosan or endotoxin induced multiple organ failure, arthritis, allergic encephalomyelitis, and diabetic islet cell destruction. Pharmacological inhibition of PARS may be a promising novel approach for the experimental therapy of various forms of inflammation.

AB - Peroxynitrite and hydroxyl radicals are potent initiators of DNA single strand breakage, which is an obligatory stimulus for the activation of the nuclear enzyme poly(ADP-ribose)synthetase (PARS). Rapid activation of PARS depletes the intracellular concentration of its substrate, NAD+, slowing the rate of glycolysis, electron transport and ATP formation. This process can result in acute cell dysfunction and cell necrosis. Accordingly, inhibitors of PARS protect against cell death under these conditions. In addition to the direct cytotoxic pathway regulated by DNA injury and PARS activation, PARS also appears to modulate the course of inflammation by regulating the expression of a number of genes, including the gene for intercellular adhesion molecule 1, collagenase and the inducible nitric oxide synthase. The research into the role of PARS in inflammatory conditions is now supported by novel tools, such as novel, potent inhibitors of PARS, and genetically engineered animals lacking the gene for PARS. In vivo data demonstrate that inhibition of PARS protects against various forms of inflammation, including zymosan or endotoxin induced multiple organ failure, arthritis, allergic encephalomyelitis, and diabetic islet cell destruction. Pharmacological inhibition of PARS may be a promising novel approach for the experimental therapy of various forms of inflammation.

KW - 3-Aminobenzamide

KW - Diabetes

KW - Endotoxin

KW - Free radical

KW - Inflammation

KW - Mitochondrial respiration

KW - Nicotinamide

KW - Nitric oxide, (NO)

KW - Peroxynitrite

KW - Poly(ADP-ribose)synthetase

KW - Septic shock

KW - Stroke

KW - Superoxide

UR - http://www.scopus.com/inward/record.url?scp=0032577469&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032577469&partnerID=8YFLogxK

U2 - 10.1016/S0014-2999(98)00249-0

DO - 10.1016/S0014-2999(98)00249-0

M3 - Article

VL - 350

SP - 1

EP - 19

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 1

ER -